Clinical Trial Update: Evaluation of Efficacy and Safety of Tralokinumab in Patients With Active, Moderate-to-severe Ulcerative Colitis [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated the efficacy and safety of tralokinumab in patients with active, moderate-to-severe ulcerative colitis; results were posted on 2016-04…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Tralokinumab (tralokinumab)

Snippet

Sponsor: AstraZeneca | Conditions: Ulcerative Colitis | Phase 2 | Status: COMPLETED | Results posted: 2016-04-05